Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


22.11.2021

1 Adv Respir Med
1 Am J Cardiol
1 Am J Respir Cell Mol Biol
2 Am J Respir Crit Care Med
1 Am Surg
1 Ann Palliat Med
1 Bioengineered
2 BMC Pulm Med
2 Cells
1 Circ Heart Fail
1 Clin Exp Rheumatol
1 Clin Res Cardiol
1 Comb Chem High Throughput Screen
1 Compr Physiol
1 Drug Deliv
1 ESC Heart Fail
3 Eur Respir J
1 Expert Rev Respir Med
1 Front Cardiovasc Med
2 Front Med (Lausanne)
1 Front Pediatr
1 Front Vet Sci
1 Heart Lung
1 Heart Surg Forum
1 Int J Environ Res Public Health
1 Int J Gen Med
1 Intern Emerg Med
1 J Assoc Physicians India
1 J Clin Anesth
1 J Clin Med
1 J Comput Biol
1 J Thorac Dis
1 J Thromb Thrombolysis
2 Kardiologiia
1 Mol Ther
1 Ophthalmol Retina
1 Perfusion
1 Pharmacol Res
1 Pharmacol Res Perspect
1 Physiol Rep
2 Pulm Circ
1 Radiol Case Rep
1 Respir Physiol Neurobiol
1 Sci Rep
2 Ther Adv Respir Dis
1 Zhonghua Xin Xue Guan Bing Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Respir Med

  1. PERVAIZ A, El-Baba F, Dhillon K, Daoud A, et al
    Pulmonary complications of sickle cell disease: a narrative clinical review.
    Adv Respir Med. 2021;89:173-187.
    PubMed         Abstract available


    Am J Cardiol

  2. HU S, Tan JS, Liu S, Guo TT, et al
    Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Am J Cardiol. 2021 Nov 10. pii: S0002-9149(21)01008.
    PubMed         Abstract available


    Am J Respir Cell Mol Biol

  3. KOLESNICHENKO OA, Whitsett JA, Kalin TV, Kalinichenko VV, et al
    Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases.
    Am J Respir Cell Mol Biol. 2021;65:473-488.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  4. VILLAFRANCO N, Varghese N, Sockrider M, Ely E, et al
    Pulmonary Hypertension in Children Part 1: Causes and Symptoms.
    Am J Respir Crit Care Med. 2021;204:P17-P18.
    PubMed        

  5. NATHAN SD, Tapson VF, Elwing J, Rischard F, et al
    Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial.
    Am J Respir Crit Care Med. 2021 Nov 12. doi: 10.1164/rccm.202107-1766.
    PubMed         Abstract available


    Am Surg

  6. ALQASSIEH A, Dennis PB, Mehta V, Shi J, et al
    MILLER Banding Procedure for Treatment of Dialysis Access-Related Steal Syndrome, Pulmonary Hypertension, and Heart Failure.
    Am Surg. 2021 Nov 18:31348211056259. doi: 10.1177/00031348211056259.
    PubMed         Abstract available


    Ann Palliat Med

  7. WANG L, Zhu L, Wu Y, Li Q, et al
    Riociguat therapy for pulmonary hypertension: a systematic review and meta-analysis.
    Ann Palliat Med. 2021;10:11117-11128.
    PubMed         Abstract available


    Bioengineered

  8. ZENG Y, Li N, Zheng Z, Chen R, et al
    Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis.
    Bioengineered. 2021;12:2576-2591.
    PubMed         Abstract available


    BMC Pulm Med

  9. CURRIE BM, Davies EW, Beaudet A, Stassek L, et al
    Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    BMC Pulm Med. 2021;21:365.
    PubMed         Abstract available

  10. KAMP JC, Fuge J, Karsten JF, Rumke S, et al
    Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension.
    BMC Pulm Med. 2021;21:164.
    PubMed         Abstract available


    Cells

  11. FAZAL S, Bisserier M, Hadri L
    Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension.
    Cells. 2021;10.
    PubMed         Abstract available

  12. HAN Y, Ali MK, Dua K, Spiekerkoetter E, et al
    Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.
    Cells. 2021;10.
    PubMed         Abstract available


    Circ Heart Fail

  13. LEOPOLD JA, Kawut SM, Aldred MA, Archer SL, et al
    Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop.
    Circ Heart Fail. 2021;14.
    PubMed         Abstract available


    Clin Exp Rheumatol

  14. JU C, Lian Q, Chen A, Xu X, et al
    Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study.
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17604.
    PubMed         Abstract available


    Clin Res Cardiol

  15. GUAL-CAPLLONCH F, Lupon J, Bancu I, Graterol F, et al
    Preload dependence of pulmonary haemodynamics and right ventricular performance.
    Clin Res Cardiol. 2021;110:591-600.
    PubMed         Abstract available


    Comb Chem High Throughput Screen

  16. WU P, Xie X, Chen M, Sun J, et al
    Elucidation of the Mechanisms and Molecular Targets of Qishen Yiqi Formula for the Treatment of Pulmonary Arterial Hypertension using a Bioinformatics/Network Topology-based Strategy.
    Comb Chem High Throughput Screen. 2021;24:701-715.
    PubMed         Abstract available


    Compr Physiol

  17. DEL VALLE K, DuBrock HM
    Hepatopulmonary Syndrome and Portopulmonary Hypertension: Pulmonary Vascular Complications of Liver Disease.
    Compr Physiol. 2021;11:1-22.
    PubMed         Abstract available


    Drug Deliv

  18. FU W, He W, Li Y, Chen Y, et al
    Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis.
    Drug Deliv. 2021;28:1007-1019.
    PubMed         Abstract available


    ESC Heart Fail

  19. BAUER F, Besnier E, Aludaat C, Breil R, et al
    Left atrial unloading with an 8 mm septal cutting balloon to treat postcapillary pulmonary hypertension: a case report.
    ESC Heart Fail. 2021 Nov 11. doi: 10.1002/ehf2.13671.
    PubMed         Abstract available


    Eur Respir J

  20. PETERS EL, Bogaard HJ, Vonk Noordegraaf A, de Man FS, et al
    Neurohormonal modulation in pulmonary arterial hypertension.
    Eur Respir J. 2021;58.
    PubMed         Abstract available

  21. VALENTIN S, Maurac A, Sitbon O, Beurnier A, et al
    Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs.
    Eur Respir J. 2021;58.
    PubMed         Abstract available

  22. CALLEJO M, Blanco I, Barbera JA, Perez-Vizcaino F, et al
    Vitamin D deficiency, a potential cause for insufficient response to sildenafil in pulmonary arterial hypertension.
    Eur Respir J. 2021;58.
    PubMed        


    Expert Rev Respir Med

  23. CHURCH C, Gin-Sing W, Grady D, Johnson M, et al
    Establishing expert consensus for the optimal approach to holistic risk-management in pulmonary arterial hypertension: a Delphi process and narrative review.
    Expert Rev Respir Med. 2021;15:1493-1503.
    PubMed         Abstract available


    Front Cardiovasc Med

  24. HU B, Xu G, Jin X, Chen D, et al
    Novel Prognostic Predictor for Primary Pulmonary Hypertension: Focus on Blood Urea Nitrogen.
    Front Cardiovasc Med. 2021;8:724179.
    PubMed         Abstract available


    Front Med (Lausanne)

  25. GONCHAROVA EA, Bogaard HJ, de Jesus Perez VA
    Editorial: Pulmonary Hypertension in the Modern Era: Science and Clinical Practice.
    Front Med (Lausanne). 2021;8:785181.
    PubMed        

  26. PANG W, Zhang Z, Wang Z, Zhen K, et al
    Higher Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism in Asians Than in Europeans: A Meta-Analysis.
    Front Med (Lausanne). 2021;8:721294.
    PubMed         Abstract available


    Front Pediatr

  27. ZHOU R, Zheng YN, Zhang XY, Cheng YY, et al
    A Meta-Analysis of the Risk Factors of Persistent Pulmonary Hypertension in Newborns.
    Front Pediatr. 2021;9:659137.
    PubMed         Abstract available


    Front Vet Sci

  28. SUZUKI R, Yuchi Y, Kanno H, Saito T, et al
    Pulmonary Vascular Resistance Estimated by Echocardiography in Dogs With Myxomatous Mitral Valve Disease and Pulmonary Hypertension Probability.
    Front Vet Sci. 2021;8:771726.
    PubMed         Abstract available


    Heart Lung

  29. WALS-RODRIGUEZ AJ, Rodriguez-Puras MJ, Garcia-Orta R, Robledo J, et al
    Pulmonary hypertension in adults with congenital heart disease. Clinical phenotypes and outcomes in the advanced pulmonary vasodilator era.
    Heart Lung. 2021;51:75-81.
    PubMed         Abstract available


    Heart Surg Forum

  30. MATKOVIC M, Milicevic V, Bilbija I, Aleksic N, et al
    Pulmonary Artery Hypertension as A Risk Factor for Long-Term Survival after Heart Transplantation.
    Heart Surg Forum. 2021;24:E544-E549.
    PubMed         Abstract available


    Int J Environ Res Public Health

  31. SHIHAN M, Novoyatleva T, Lehmeyer T, Sydykov A, et al
    Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.
    Int J Environ Res Public Health. 2021;18.
    PubMed         Abstract available


    Int J Gen Med

  32. MA RZ, Han PP, Tao XC, Li H, et al
    A Feasibility Study on Using Single-Photon Emission Computed Tomography Pulmonary Perfusion/Ventilation Imaging for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension and Patient Risk Assessment.
    Int J Gen Med. 2021;14:8029-8038.
    PubMed         Abstract available


    Intern Emerg Med

  33. LACEDONIA D, Correale M, Tricarico L, Scioscia G, et al
    Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone.
    Intern Emerg Med. 2021 Nov 16. pii: 10.1007/s11739-021-02883.
    PubMed         Abstract available


    J Assoc Physicians India

  34. MANN A, Kampani G, Bansal S, Ranga S, et al
    Study of Pulmonary Arterial Hypertension in Patients of Chronic Kidney Disease Stage IV and V.
    J Assoc Physicians India. 2021;69:11-12.
    PubMed         Abstract available


    J Clin Anesth

  35. ZANG H, Yan W, Xie W
    Comment on "The direct comparison of inhaled versus intravenous levosimendan in children with pulmonary hypertension undergoing on-cardiopulmonary bypass cardiac surgery: A randomized, controlled, non-inferiority study".
    J Clin Anesth. 2021;76:110572.
    PubMed        


    J Clin Med

  36. GOULABCHAND R, Roubille C, Montani D, Fesler P, et al
    Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjogren's Syndrome: Data from the French Health Insurance Database.
    J Clin Med. 2021;10.
    PubMed         Abstract available


    J Comput Biol

  37. ZHAO E, Xie H, Zhang Y
    Identification of Differentially Expressed Genes Associated with Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Approaches.
    J Comput Biol. 2021;28:79-88.
    PubMed         Abstract available


    J Thorac Dis

  38. YAMAMOTO H, Sugimoto S, Imanishi K, Hashimoto K, et al
    Meticulous closure of collateral vessels in the perihilar mediastinal pleura to control intraoperative bleeding during lung transplantation for pulmonary hypertension.
    J Thorac Dis. 2021;13:5658-5669.
    PubMed         Abstract available


    J Thromb Thrombolysis

  39. LI JF, Wu LJ, Wen GY, Zhou RR, et al
    Platelet count trends and response to fondaparinux in a cohort of heparin-induced thrombocytopenia suspected patients after pulmonary endarterectomy.
    J Thromb Thrombolysis. 2021;51:703-710.
    PubMed         Abstract available


    Kardiologiia

  40. GRATSIANSKAYA SE, Demchenkova AY, Martynyuk TV, Veselova TN, et al
    Case report of mild form of a new coronavirus infection in patient with idiopathic pulmonary hypertension.
    Kardiologiia. 2021;61:108-112.
    PubMed         Abstract available

  41. PROSHKINA AA, Tsareva NA, Nekludova GV, Avdeev SN, et al
    [Triple combination therapy with macitentan, riociguat, and selexipag in a patient with idiopathic pulmonary arterial hypertension (functional class III)].
    Kardiologiia. 2021;61:104-107.
    PubMed         Abstract available


    Mol Ther

  42. LI Y, Zhang J, Sun H, Chen Y, et al
    lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia.
    Mol Ther. 2021;29:1411-1424.
    PubMed         Abstract available


    Ophthalmol Retina

  43. LAURA DM, Staropoli PC, Patel NA, Yannuzzi NA, et al
    Widefield Fluorescein Angiography in the Fellow Eyes of Patients with Presumed Unilateral Persistent Fetal Vasculature.
    Ophthalmol Retina. 2021;5:301-307.
    PubMed         Abstract available


    Perfusion

  44. JIANG Y, Lou M, Chu X, Zheng D, et al
    Use of venous-venous extracorporeal membrane oxygenation in the treatment of postpartum pulmonary hypertension crisis.
    Perfusion. 2021 Nov 11:2676591211043705. doi: 10.1177/02676591211043705.
    PubMed         Abstract available


    Pharmacol Res

  45. MIRHADI E, Roufogalis BD, Banach M, Barati M, et al
    Resveratrol: Mechanistic and therapeutic perspectives in pulmonary arterial hypertension.
    Pharmacol Res. 2021;163:105287.
    PubMed         Abstract available


    Pharmacol Res Perspect

  46. XUE X, Zhang S, Jiang W, Wang J, et al
    Protective effect of baicalin against pulmonary arterial hypertension vascular remodeling through regulation of TNF-alpha signaling pathway.
    Pharmacol Res Perspect. 2021;9:e00703.
    PubMed         Abstract available


    Physiol Rep

  47. DOUGLASS M, Dikalova A, Kaplowitz MR, Zhang Y, et al
    Folic acid, either solely or combined with L-citrulline, improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.
    Physiol Rep. 2021;9:e15096.
    PubMed         Abstract available


    Pulm Circ

  48. MCCORMACK C, Cullivan S, Kehoe B, McCaffrey N, et al
    "It is the fear of exercise that stops me" - attitudes and dimensions influencing physical activity in pulmonary hypertension patients.
    Pulm Circ. 2021;11:20458940211056509.
    PubMed         Abstract available

  49. BUEHLER PW, Swindle D, Pak DI, Fini MA, et al
    Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features.
    Pulm Circ. 2021;11:20458940211055996.
    PubMed         Abstract available


    Radiol Case Rep

  50. RAMDANI H, Benelhosni K, Billah NM, Nassar I, et al
    An unusual cause of pulmonary hypertension: Mediastinal hydatid cyst.
    Radiol Case Rep. 2021;17:86-90.
    PubMed         Abstract available


    Respir Physiol Neurobiol

  51. RONCATO G, da Fontoura FF, Spilimbergo FB, Meyer GMB, et al
    Parasympathetic modulation withdrawal improves functional capacity in pulmonary arterial hypertension.
    Respir Physiol Neurobiol. 2021;287:103620.
    PubMed         Abstract available


    Sci Rep

  52. SHARIFI KIA D, Fortunato R, Maiti S, Simon MA, et al
    An exploratory assessment of stretch-induced transmural myocardial fiber kinematics in right ventricular pressure overload.
    Sci Rep. 2021;11:3587.
    PubMed         Abstract available


    Ther Adv Respir Dis

  53. EXPOSTO F, Hermans R, Nordgren A, Taylor L, et al
    Burden of pulmonary arterial hypertension in England: retrospective HES database analysis.
    Ther Adv Respir Dis. 2021;15:1753466621995040.
    PubMed         Abstract available

  54. MOMOI M, Hiraide T, Shinya Y, Momota H, et al
    Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2021;15:1753466621995048.
    PubMed         Abstract available


    Zhonghua Xin Xue Guan Bing Za Zhi

  55. SHI J, Liang JW, Chen Y, Ying MJ, et al
    [A case report of percutaneous transluminal pulmonary angioplasty applied to chronic thromboembolic pulmonary hypertension associated with essential thrombocythemia].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2021;49:1139-1142.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: